Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?

Could optimal systemic therapy be adequate without locoregional therapy?

Date

13 Sep 2024

Session

Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?

Topics

Tumour Site

Urothelial Cancer

Presenters

Srikala Sridhar

Authors

S.S. Sridhar

Author affiliations

  • Medical Oncology Department, UHN - University Health Network - Princess Margaret Cancer Center, M5G 2M9 - Toronto/CA

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction and scientific background

Presenter: Leslie Ballas

Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?

Resources:

Slides

Webcast

Q&A and discussion

Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?

Resources:

Webcast

Conclusions and perspectives

Presenter: Srikala Sridhar

Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.